Compass Financial Management
BMY icon

Compass Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Compass Financial Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$913K Sell
14,628
-338
-2% -$21.4K 0.1% 201
2026
Q2 		$932K Buy
+14,966
New +$859K 0.11% 189

Other funds holding BMY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Compass Financial Management's BMY Position: Q3 2026 in Review

Compass Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q3 2026, selling an estimated $21.4K and leaving 14,628 shares worth $913K. The position accounts for 0.1% of the portfolio, ranked #201.

Compass Financial Management first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. The position peaked at $932K in Q2 2026. 2,186 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Compass Financial Management held 14,628 shares of Bristol-Myers Squibb worth $913K as of Q3 2026.
  • Compass Financial Management sold 338 Bristol-Myers Squibb shares in Q3 2026, an estimated $21.4K.
  • Bristol-Myers Squibb made up 0.1% of Compass Financial Management's portfolio in Q3 2026, its #201 holding.
  • Compass Financial Management first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
  • Compass Financial Management's Bristol-Myers Squibb position peaked at $932K in Q2 2026.
  • 2,186 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.